Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Epoprostenol

Known as: PGI2, PGX, Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9alpha,11alpha,13E,15S)- 
An oral prostacyclin and a metabolite of arachidonic acid with antihypertensive and platelet inhibitory properties. Epoprostenol binds to… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Although exercise is associated with depression relief, the effects of aerobic exercise (AE) interventions on clinically… Expand
Review
2018
Review
2018
The incidence and prevalence of diabetes mellitus is rapidly increasing worldwide at an alarming rate. Type 2 diabetes mellitus… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2018
Review
2018
Group 2 innate lymphoid cells (ILC2s) play critical roles in the induction of type 2 inflammation, response to parasite infection… Expand
Review
2018
Review
2018
Platelets are circulating sentinels of vascular integrity and are activated, inhibited, or modulated by multiple hormones… Expand
Review
2018
Review
2018
G-protein-coupled receptors (GPCRs, also called seven-transmembrane or heptahelical receptors) are a superfamily of cell surface… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2017
Review
2017
Endothelial cells, as well as their major products nitric oxide (NO) and prostacyclin, play a key role in the regulation of… Expand
Review
2017
Review
2017
BACKGROUND Bi-allelic mutations of the EIF2AK4 gene cause heritable pulmonary veno-occlusive disease and/or pulmonary capillary… Expand
Highly Cited
2002
Highly Cited
2002
OBJECTIVES We sought to determine the factors associated with long-term survival in patients with primary pulmonary hypertension… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Highly Cited
2002
Highly Cited
2002
Background—Primary pulmonary hypertension (PPH) is a severe and progressive disease. Without treatment, the median survival is 2… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1996
Highly Cited
1996
BACKGROUND Primary pulmonary hypertension is a progressive disease for which no treatment has been shown in a prospective… Expand